Economic Aspects of Pneumococcal Pneumonia
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 22 (11), 719-740
- https://doi.org/10.2165/00019053-200422110-00003
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Impact of the pneumococcal conjugate vaccine on otitis mediaThe Pediatric Infectious Disease Journal, 2003
- Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?Health Economics, 2002
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The NetherlandsPharmacoEconomics, 2001
- Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European CountriesClinical Infectious Diseases, 2000
- Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacinClinical Therapeutics, 2000
- Cost-Effectiveness of the Pneumococcal Vaccine in the United States Navy and Marine CorpsClinical Infectious Diseases, 2000
- The Cost of Treating Patients with Community-Acquired PneumoniaSeminars in Respiratory and Critical Care Medicine, 1999
- PHARMACOECONOMIC EVALUATION OF ALTERNATIVE ANTIBIOTIC REGIMENS IN HOSPITALIZED PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIAInfectious Diseases in Clinical Practice, 1998
- Pneumonia Caused by Penicillin-non-susceptible and Penicillin-susceptible Pneumococci in Adults: A Case-Control StudyScandinavian Journal of Infectious Diseases, 1998